The global cell therapy technologies market is projected to
reach USD 8.0 billion by 2027 from USD 4.0 billion in 2022, at a CAGR of 14.6%
during the forecast period. Market growth is driven mainly by increasing
research in regenerative medicine along with stem cell research, cancer
research, and cell biology research.
Request for Sample PDF Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978
The global cell therapy technologies market is consolidated.
The prominent players operating in this market include Thermo Fisher
Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza
Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Becton, Dickinson
and Company (US), Fresenius SE & Co. KGaA (Germany), Avantor, Inc. (US),
Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine
Scientific (US), MaxCyte Inc. (US), Werum IT Solutions GmbH (Germany),
RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), TrakCel (UK), L7 Informatics,
Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), GPI
Iberia (Spain), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology
(China), and Wilson Wolf Manufacturing Corporation (US).
Thermo Fisher Scientific
Thermo Fisher Scientific offers a complete and integrated
portfolio of solutions and services for clinical science, laboratory research,
and analysis. It operates in four business segments—Life Sciences Solutions,
Analytical Instruments, Specialty Diagnostics, and Laboratory Products and
Services. Its Life Sciences Solutions segment offers a wide range of reagents,
instruments, and consumables used in biological and medical research, discovery
and production of new drugs and vaccines, as well as the diagnosis of diseases.
Merck KGaA
Merck operates through three business segments, namely,
Healthcare, Life Science, and Performance Materials. The Life Science segment
offers life science products and services for research and diagnostic purposes.
Merck offers products in the cell therapy technologies market through its Life
Science segment.
Danaher Corporation
Danaher Corporation operates through three strategic
segments—Environmental and Applied Solutions, Life Sciences, and Diagnostics.
The Diagnostics segment offers a wide range of products through its key
brands—SCIEX, Beckman Coulter, Leica Biosystems, Leica Microsystems,
Radiometer, and Cepheid. Beckman Coulter and Cytiva, subsidiaries of Danaher
Corporation, cater to the cell therapy technologies market. Beckman develops,
manufactures, and markets products in automation, diagnostics, and chemistry.
Browse Complete Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html
The Asia Pacific region is the fastest-growing region of
the cell therapy technologies market
The Asia Pacific is estimated to be the fastest-growing
segment of the market. The growth of the cell therapy technologies market of
the region is mostly driven by their low labor and manufacturing costs, which
has drawn huge investments by biopharma giants to these countries.
Recent Developments
·
Thermo Fisher Scientific launched the first
T-cell medium designed specifically for allogeneic cell therapy workflows.
·
Danaher acquired the Biopharma business from
General Electric Company's Life Sciences division. The acquisition has led to
the formation of a new business named Cytiva, a standalone operating company
within Danaher's Life Sciences segment.
Buy-Now this Premium Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=213334978
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B
research on 30,000 high growth niche opportunities/threats which will impact
70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers
worldwide including 80% of global Fortune 1000 companies as clients. Almost
75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most important
customers, write "Attack, avoid and defend" strategies, identify
sources of incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets’s flagship competitive
intelligence and market research platform, "Knowledgestore" connects
over 200,000 markets and entire value chains for deeper understanding of the
unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The Wall